annual cash & cash equivalents:
$392.10M+$196.29M(+100.25%)Summary
- As of today (September 16, 2025), OCUL annual cash & cash equivalents is $392.10 million, with the most recent change of +$196.29 million (+100.25%) on December 31, 2024.
- During the last 3 years, OCUL annual cash & cash equivalents has risen by +$227.94 million (+138.85%).
- OCUL annual cash & cash equivalents is now at all-time high.
Performance
OCUL Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$391.13M+$41.45M(+11.85%)Summary
- As of today (September 16, 2025), OCUL quarterly cash & cash equivalents is $391.13 million, with the most recent change of +$41.45 million (+11.85%) on June 30, 2025.
- Over the past year, OCUL quarterly cash & cash equivalents has dropped by -$68.56 million (-14.91%).
- OCUL quarterly cash & cash equivalents is now -19.03% below its all-time high of $483.04 million, reached on March 31, 2024.
Performance
OCUL quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
OCUL Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.3% | -14.9% |
| 3 y3 years | +138.8% | +190.7% |
| 5 y5 years | +620.3% | +364.0% |
OCUL Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +283.3% | -19.0% | +487.2% |
| 5 y | 5-year | at high | +620.3% | -19.0% | +487.2% |
| alltime | all time | at high | +2139.9% | -19.0% | +2967.7% |
OCUL Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $391.13M(+11.9%) |
| Mar 2025 | - | $349.68M(-10.8%) |
| Dec 2024 | $392.10M(+100.2%) | $392.10M(-8.2%) |
| Sep 2024 | - | $427.22M(-7.1%) |
| Jun 2024 | - | $459.69M(-4.8%) |
| Mar 2024 | - | $483.04M(+146.5%) |
| Dec 2023 | $195.81M(+91.4%) | $195.96M(+77.3%) |
| Sep 2023 | - | $110.55M(+66.0%) |
| Jun 2023 | - | $66.61M(-15.7%) |
| Mar 2023 | - | $79.03M(-22.8%) |
| Dec 2022 | $102.30M(-37.7%) | $102.30M(-15.4%) |
| Sep 2022 | - | $120.95M(-10.1%) |
| Jun 2022 | - | $134.54M(-7.5%) |
| Mar 2022 | - | $145.42M(-11.4%) |
| Dec 2021 | $164.16M(-28.0%) | $164.16M(-8.4%) |
| Sep 2021 | - | $179.28M(-6.6%) |
| Jun 2021 | - | $191.86M(-8.4%) |
| Mar 2021 | - | $209.38M(-8.2%) |
| Dec 2020 | $228.06M(+318.9%) | $228.06M(+222.8%) |
| Sep 2020 | - | $70.64M(-16.2%) |
| Jun 2020 | - | $84.29M(+75.1%) |
| Mar 2020 | - | $48.15M(-11.5%) |
| Dec 2019 | $54.44M | $54.44M(-16.8%) |
| Sep 2019 | - | $65.41M(+5.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $61.77M(-19.0%) |
| Mar 2019 | - | $76.25M(+41.0%) |
| Dec 2018 | $54.06M(+30.2%) | $54.06M(-4.9%) |
| Sep 2018 | - | $56.86M(+0.0%) |
| Jun 2018 | - | $56.83M(-9.7%) |
| Mar 2018 | - | $62.91M(+51.5%) |
| Dec 2017 | $41.54M(+26.1%) | $41.54M(-18.8%) |
| Sep 2017 | - | $51.16M(-22.5%) |
| Jun 2017 | - | $66.05M(-17.8%) |
| Mar 2017 | - | $80.38M(+18.0%) |
| Dec 2016 | $32.94M(+7.0%) | $68.14M(-10.0%) |
| Sep 2016 | - | $75.75M(-9.7%) |
| Jun 2016 | - | $83.89M(-12.1%) |
| Mar 2016 | - | $95.46M(-9.1%) |
| Dec 2015 | $30.78M(-17.7%) | $105.06M(-7.5%) |
| Sep 2015 | - | $113.64M(-8.2%) |
| Jun 2015 | - | $123.78M(+83.6%) |
| Mar 2015 | - | $67.42M(-10.0%) |
| Dec 2014 | $37.39M(+113.6%) | $74.89M(-7.4%) |
| Sep 2014 | - | $80.89M(+305.6%) |
| Jun 2014 | - | $19.94M(+56.4%) |
| Mar 2014 | - | $12.75M(-27.2%) |
| Dec 2013 | $17.50M(-26.6%) | $17.50M |
| Dec 2012 | $23.85M | - |
FAQ
- What is Ocular Therapeutix, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Ocular Therapeutix, Inc.?
- What is Ocular Therapeutix, Inc. annual cash & cash equivalents year-on-year change?
- What is Ocular Therapeutix, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Ocular Therapeutix, Inc.?
- What is Ocular Therapeutix, Inc. quarterly cash & cash equivalents year-on-year change?
What is Ocular Therapeutix, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of OCUL is $392.10M
What is the all time high annual cash & cash equivalents for Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. all-time high annual cash & cash equivalents is $392.10M
What is Ocular Therapeutix, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, OCUL annual cash & cash equivalents has changed by +$196.29M (+100.25%)
What is Ocular Therapeutix, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of OCUL is $391.13M
What is the all time high quarterly cash & cash equivalents for Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. all-time high quarterly cash & cash equivalents is $483.04M
What is Ocular Therapeutix, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, OCUL quarterly cash & cash equivalents has changed by -$68.56M (-14.91%)